# Artemether-lumefantrine for Treatment of P. Falciparum Malaria in Brazil

> **NCT02600767** · NA · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 79 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Artemether-lumefantrine combination

## Key facts

- **NCT ID:** NCT02600767
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-05
- **Final completion:** 2016-12
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2017-10-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02600767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02600767, "Artemether-lumefantrine for Treatment of P. Falciparum Malaria in Brazil". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02600767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*